Poland: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2023

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Poland

In 2021, the Polish market for hormones, prostaglandins, thromboxanes and leukotrienes decreased by -90.7% to $X, falling for the third year in a row after two years of growth. Overall, consumption saw a precipitous curtailment. Hormones, prostaglandins, thromboxanes and leukotrienes consumption peaked at $X in 2018; however, from 2019 to 2021, consumption failed to regain momentum.

Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in Poland

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production reduced to $X in 2021 estimated in export price. In general, the total production indicated tangible growth from 2012 to 2021: its value increased at an average annual rate of +3.4% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, production increased by +82.5% against 2014 indices. The most prominent rate of growth was recorded in 2020 with an increase of 22% against the previous year. As a result, production attained the peak level of $X, and then declined in the following year.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports from Poland

In 2021, shipments abroad of hormones, prostaglandins, thromboxanes and leukotrienes increased by 144% to X tons, rising for the second consecutive year after three years of decline. Overall, exports continue to indicate a significant increase. The most prominent rate of growth was recorded in 2013 with an increase of 486%. The exports peaked in 2021 and are likely to see gradual growth in the immediate term.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports soared to $X in 2021. Over the period under review, exports posted a resilient expansion. The most prominent rate of growth was recorded in 2015 when exports increased by 173% against the previous year. Over the period under review, the exports reached the peak figure at $X in 2016; however, from 2017 to 2021, the exports failed to regain momentum.

Exports by Country

Russia (X tons) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from Poland, with a 83% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to Russia exceeded the volume sent to the second major destination, the Czech Republic (X kg), more than tenfold. Denmark (X kg) ranked third in terms of total exports with a 3.3% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to Russia totaled +180.8%. Exports to the other major destinations recorded the following average annual rates of exports growth: the Czech Republic (+106.6% per year) and Denmark (+48.0% per year).

In value terms, Russia ($X) remains the key foreign market for hormones, prostaglandins, thromboxanes and leukotrienes exports from Poland, comprising 70% of total exports. The second position in the ranking was taken by Denmark ($X), with a 4.7% share of total exports. It was followed by Slovakia, with a 4.2% share.

From 2012 to 2021, the average annual rate of growth in terms of value to Russia stood at +97.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Denmark (+25.5% per year) and Slovakia (-0.6% per year).

Export Prices by Country

The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, which is down by -21.4% against the previous year. In general, the export price faced a abrupt shrinkage. The pace of growth appeared the most rapid in 2014 an increase of 161%. The export price peaked at $X per kg in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

There were significant differences in the average prices for the major overseas markets. In 2021, the country with the highest price was Bangladesh ($X per kg), while the average price for exports to China ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Bangladesh (+131.4%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports into Poland

In 2021, imports of hormones, prostaglandins, thromboxanes and leukotrienes into Poland declined to X tons, shrinking by -6.5% on the previous year's figure. Overall, total imports indicated perceptible growth from 2012 to 2021: its volume increased at an average annual rate of +3.7% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +23.9% against 2017 indices. The pace of growth appeared the most rapid in 2018 with an increase of 43% against the previous year. Over the period under review, imports hit record highs at X tons in 2016; however, from 2017 to 2021, imports remained at a lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports declined to $X in 2021. In general, imports saw a abrupt decrease. The most prominent rate of growth was recorded in 2013 when imports increased by 53% against the previous year. Over the period under review, imports reached the peak figure at $X in 2014; however, from 2015 to 2021, imports remained at a lower figure.

Imports by Country

China (X tons), India (X tons) and Germany (X tons) were the main suppliers of hormones, prostaglandins, thromboxanes and leukotrienes imports to Poland, together comprising 57% of total imports. These countries were followed by France, Italy, the Czech Republic, Spain, the UK and Ireland, which together accounted for a further 35%.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Spain (with a CAGR of +78.1%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Ireland ($X), Germany ($X) and India ($X) appeared to be the largest hormones, prostaglandins, thromboxanes and leukotrienes suppliers to Poland, with a combined 54% share of total imports. China, the UK, Italy, France, Spain and the Czech Republic lagged somewhat behind, together accounting for a further 38%.

In terms of the main suppliers, Spain, with a CAGR of +33.5%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, standing approx. at the previous year. Over the period under review, the import price saw a abrupt shrinkage. The growth pace was the most rapid in 2013 when the average import price increased by 109%. As a result, import price reached the peak level of $X per kg. From 2014 to 2021, the average import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Ireland ($X per kg), while the price for the Czech Republic ($X per kg) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Ireland (+21.3%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Market Intelligence Platform

Frequently Asked Questions (FAQ) :